|
|
Volumn 39, Issue 6, 1999, Pages 867-868
|
|
Interleukin-2 for the management of HIV infection.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
INTERLEUKIN 2;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
DRUG COMBINATION;
GENETICS;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
POINT MUTATION;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
ANTI-HIV AGENTS;
DRUG THERAPY, COMBINATION;
HIV INFECTIONS;
HUMANS;
INTERLEUKIN-2;
POINT MUTATION;
RANDOMIZED CONTROLLED TRIALS;
MLCS;
MLOWN;
|
|
EID: 0033219108
PISSN: 10865802
EISSN: None
Source Type: Journal
DOI: 10.1016/s1086-5802(15)30389-2 Document Type: Review |
|
Times cited : (5)
|
|
References (25)
|
